Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 8Head & Neck 6Thoracic 5Sarcoma 4Gynecologic 4Breast 3Genitourinary 2Dermatologic 2CNS 2Tumor-Agnostic 1Plasma cell 1Other solid neoplasm 1Other hematologic neoplasm 1Lymphoid 1Endocrine 1

Conditions

Urologic Neoplasms 1Stomach Neoplasms 1Lymphoma 1Lung Neoplasms 1Liver Neoplasms 1Leukemia 1Head and Neck Neoplasms 1Breast Neoplasms 1

Interventions

Cytarabine 905Cyclophosphamide 899fludarabine 525venetoclax 489fludarabine phosphate 468Azacitidine 460Rituximab 431Methotrexate 419Etoposide 320Filgrastim 299Busulfan 296Dexamethasone 286Vincristine 285Daunorubicin 283Peripheral Blood Stem Cell Transplantation 258Whole-Body Irradiation 243Mycophenolic Acid 232Decitabine 230Granulocyte Colony-Stimulating Factor 227Tacrolimus 220Imatinib Mesylate 211Idarubicin 205Melphalan 202Cyclosporine 182Doxorubicin 177Radiotherapy 169Prednisone 164Dasatinib 163Mitoxantrone 161Lenalidomide 160

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Tissue Banks × Other hematologic neoplasm × Clear all
NCT06827639 2025-02-14

FUTURE

Assistance Publique Hopitaux De Marseille

Not yet recruiting
640 enrolled
BreastGastrointestinalGenitourinaryHead & NeckLymphoidOther hematologic neoplasmThoracic

Breast Neoplasms, Head and Neck Neoplasms, Leukemia, Liver Neoplasms, Lung Neoplasms, Lymphoma, Stomach Neoplasms, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡